204 related articles for article (PubMed ID: 7679844)
1. Human mouse chimeric CD7 monoclonal antibody (SDZCHH380) for the prophylaxis of kidney transplant rejection.
Lazarovits AI; Rochon J; Banks L; Hollomby DJ; Muirhead N; Jevnikar AM; White MJ; Amlot PL; Beauregard-Zollinger L; Stiller CR
Transplant Proc; 1993 Feb; 25(1 Pt 1):820-2. PubMed ID: 7679844
[No Abstract] [Full Text] [Related]
2. Human mouse chimeric CD7 monoclonal antibody (SDZCHH380) for the prophylaxis of kidney transplant rejection.
Lazarovits AI; Rochon J; Banks L; Hollomby DJ; Muirhead N; Jevnikar AM; White MJ; Amlot PL; Beauregard-Zollinger L; Stiller CR
J Immunol; 1993 Jun; 150(11):5163-74. PubMed ID: 7684422
[TBL] [Abstract][Full Text] [Related]
3. Human mouse chimeric CD7 monoclonal antibody (SDZCHH380) for the prophylaxis of kidney transplant rejection: analysis beyond 4 years.
Sharma LC; Muirhead N; Lazarovits AI
Transplant Proc; 1997; 29(1-2):323-4. PubMed ID: 9123021
[No Abstract] [Full Text] [Related]
4. [The immunobiology of transplant rejection and its pharmacological modification].
Köhler H; Zanker B; Strom TB
Dtsch Med Wochenschr; 1991 Feb; 116(7):264-9. PubMed ID: 1825196
[No Abstract] [Full Text] [Related]
5. OKT3 prophylaxis in kidney transplant recipients: drug monitoring by flow cytometry.
Cinti P; Cocciolo P; Evangelista B; Orlandini AM; Bruzzone P; Renna Molajoni E; Cortesini R
Transplant Proc; 1996 Dec; 28(6):3214-6. PubMed ID: 8962245
[No Abstract] [Full Text] [Related]
6. The clinical application of monoclonal antibody therapies in renal transplantation.
Dhanireddy KK; Xu H; Mannon RB; Hale DA; Kirk AD
Expert Opin Emerg Drugs; 2004 May; 9(1):23-37. PubMed ID: 15155134
[TBL] [Abstract][Full Text] [Related]
7. Refractory acute kidney transplant rejection with CD20 graft infiltrates and successful therapy with rituximab.
Alausa M; Almagro U; Siddiqi N; Zuiderweg R; Medipalli R; Hariharan S
Clin Transplant; 2005 Feb; 19(1):137-40. PubMed ID: 15659147
[TBL] [Abstract][Full Text] [Related]
8. Immunosuppressive drugs for kidney transplantation.
Halloran PF
N Engl J Med; 2004 Dec; 351(26):2715-29. PubMed ID: 15616206
[No Abstract] [Full Text] [Related]
9. Chimeric CD7 monoclonal antibody therapy in rheumatoid arthritis.
Kirkham BW; Thien F; Pelton BK; Pitzalis C; Amlot P; Denman AM; Panayi GS
J Rheumatol; 1992 Sep; 19(9):1348-52. PubMed ID: 1279168
[TBL] [Abstract][Full Text] [Related]
10. New insights into therapy with monoclonal antibodies in allograft transplantation.
Schena FP
Nephrol Dial Transplant; 1997; 12 Suppl 1():55-8. PubMed ID: 9075230
[No Abstract] [Full Text] [Related]
11. Expansion of CD4+CD7- T helper cells with a TH0-TH2 function in kidney transplant recipients.
Barrou B; Legac E; Blanc C; Bitker MO; Luciani J; Chatelain C; Debré P; Autran B
Transplant Proc; 1995 Apr; 27(2):1676-7. PubMed ID: 7536977
[No Abstract] [Full Text] [Related]
12. The utility of monoclonal antibody therapy in renal transplantation.
Loertscher R
Transplant Proc; 2002 May; 34(3):797-800. PubMed ID: 12034186
[No Abstract] [Full Text] [Related]
13. Review and preview of anti-T-cell antibodies.
Helderman JH
Transplant Proc; 1995 Oct; 27(5 Suppl 1):8-9. PubMed ID: 7482824
[No Abstract] [Full Text] [Related]
14. Selection and chimerization of a monoclonal CD4 antibody for heart transplantation.
Reiter C; Meiser BM; Uberfuhr P; Wenke K; Reichenspurner H; Kreuzer E; Rieber EP; Riethmüller G; Reichart B
Transplant Proc; 1993 Feb; 25(1 Pt 1):788-9. PubMed ID: 8438481
[No Abstract] [Full Text] [Related]
15. Monoclonal antibodies in organ transplantation.
Valdés RH
Transplant Proc; 1996 Dec; 28(6):3293. PubMed ID: 8962277
[No Abstract] [Full Text] [Related]
16. Peripheral blood monitoring during and after rejection-prophylaxis with a monoclonal anti-interleukin-2-receptor antibody in kidney and heart transplant recipients.
van Gelder T; Knoop CJ; Hesse CJ; Vaessen LM; Balk AH; Yzermans JN; Weimar W
Transplant Proc; 1995 Feb; 27(1):856-8. PubMed ID: 7879206
[No Abstract] [Full Text] [Related]
17. In situ antigenic modulation of human graft-infiltrating T cells is induced by OKT3 treatment.
Caillat-Zucman S; Legendre C; Noel LH; Bach JF; Kreis H; Chatenoud L
Transplant Proc; 1990 Aug; 22(4):1782. PubMed ID: 2143860
[No Abstract] [Full Text] [Related]
18. Prophylactic use of the anti-IL-2 receptor monoclonal antibody LO-Tact-1 in cadaveric renal transplantation: results of a randomized study.
Kriaa F; Hiesse C; Alard P; Lantz O; Noury J; Charpentier B; Bazin H
Transplant Proc; 1993 Feb; 25(1 Pt 1):817-9. PubMed ID: 8438496
[No Abstract] [Full Text] [Related]
19. The potential role of therapeutic antibodies in the regulation of rejection.
Ettenger RB; Yadin O
Transplant Proc; 1995 Oct; 27(5 Suppl 1):13-7. PubMed ID: 7482810
[No Abstract] [Full Text] [Related]
20. Humoral immune response against OKT3.
Chatenoud L
Transplant Proc; 1993 Apr; 25(2 Suppl 1):68-73. PubMed ID: 8465430
[No Abstract] [Full Text] [Related]
[Next] [New Search]
